Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uveitis in Gaucher disease.

Altoon Dweck1, Jaacov Rozenman, Suzy Ronen

  • 1Gaucher Clinic, Shaare Zedek Medical Center, Jerusalem, Israel. gaucher@szmc.org.il

American Journal of Ophthalmology
|July 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucosylsphingosine (Lyso-Gb1) Dynamics in Untreated States in Gaucher Disease.

International journal of molecular sciences·2026
Same author

Improvement of Bone Mineral Density in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: Results from Clinical Studies.

Journal of clinical medicine·2026
Same author

MyGauch<sup>TM</sup>: a patient-centered digital health app for Gaucher disease.

mHealth·2025
Same author

A large long-term database of Gaucher disease patients demonstrates increased risk of lymphoma and myeloma, but not of solid tumours.

Internal medicine journal·2025
Same author

Effect of Exposure to Enzyme Replacement Therapy on Bone Mineral Density in Children With Gaucher Disease.

Journal of inherited metabolic disease·2025
Same author

Prodromal Parkinsonian Features in Carriers of Gaucher Disease Compared to Controls.

Life (Basel, Switzerland)·2025
Same journal

Corneal sensitivity changes and nerve plexus abnormalities in noninfectious anterior uveitis.

American journal of ophthalmology·2026
Same journal

Role of Menopausal Hormone Therapy on Strabismus, Strabismus Surgery, and Reoperation Rates.

American journal of ophthalmology·2026
Same journal

Clinical Utility of Ultra-Widefield Swept-Source OCT for Intraocular Tumors: Comparison With Ultrasonography, SD-OCT, and MRI.

American journal of ophthalmology·2026
Same journal

Therapeutic Advances in Corneal Scar management: Topical Treatments, Mesenchymal Cell Therapy and Stromal Transplantation.

American journal of ophthalmology·2026
Same journal

Increased Risk for Ocular Surface Neoplasia in Recipients of Solid Organ Transplant.

American journal of ophthalmology·2026
Same journal

Aflibercept With vs Without Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: Optical Coherence Tomography Angiographic changes from a randomized clinical trial.

American journal of ophthalmology·2026
See all related articles

Two Gaucher disease patients experienced uveitis, with varied outcomes. One case responded well to corticosteroids, while another progressed despite enzyme replacement therapy.

Area of Science:

  • Ophthalmology
  • Genetics
  • Internal Medicine

Background:

  • Gaucher disease is a rare genetic disorder.
  • Chronic uveitis is an ocular inflammation.

Observation:

  • This study reports on two patients with type I Gaucher disease and uveitis.
  • The incidence of uveitis in Gaucher disease patients was found to be 0.4%.

Findings:

  • Uveitis management varied significantly between the two patients.
  • One patient achieved long-term uveitis control with topical corticosteroids.
  • The other patient experienced uveitis progression despite enzyme replacement therapy.

Implications:

  • These findings highlight the heterogeneous presentation and response to treatment of uveitis in Gaucher disease.

Related Experiment Videos

  • Further research is needed to understand the complex interplay between Gaucher disease and ocular inflammation.
  • Management strategies for uveitis in Gaucher disease patients may require individualized approaches.